University of Colorado Cancer Center NCI-Designated Comprehensive Cancer Center

home / authors / university-of-colorado-cancer-center-nci-designated-comprehensive-cancer-center

Articles

Dr Wells Messersmith, Chief Medical Officer, Oncology Services, UCHealth University of Colorado Hospital

Colorado School of Public Health Launches Innovative Program to Support Working Cancer Patients

University of Colorado Cancer Center NCI-Designated Comprehensive Cancer Center
August 8th 2024

The Colorado School of Public Health announces the launch of WeCanWork, a program to provide support to cancer patients as they balance work and treatment.

Read More

Latest Updated Articles

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma
Published: May 27th 2024 | Updated: September 13th 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Published: August 22nd 2024 | Updated: August 29th 2024
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
Long-term Follow-up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer: A Prespecified Subgroup Analysis From the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study
Published: August 6th 2024 | Updated: August 19th 2024
Long-term Follow-up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer: A Prespecified Subgroup Analysis From the Phase 3 ENGOT-EN5/GOG-3055/SIENDO Study
Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Xinan Sheng, MD, of Peking University Cancer Hospital and Institute
Published: September 17th 2024 | Updated: September 19th 2024
Benmelstobart Plus Anlotinib Demonstrates Efficacy in Frontline Advanced RCC